Trial site
Kootenai Health
Coeur d'Alene, Idaho 83814, United StatesNot linked to an institution yet
The trials here
What the 4 trials at this site are about, from their registry records.
- Phase
- Phase 32 trials
- Phase 41 trial
- Status
- Active, not recruiting2 trials
- Recruiting2 trials
- Lead sponsor
- Gilead Sciences1 trial
- Janssen Research & Development, LLC1 trial
- Novartis Pharmaceuticals1 trial
- University of Idaho1 trial
Running trials
Active, not recruiting
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide
NCT06208150· Phase 3· Janssen Research & Development, LLC· Source
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
NCT05633654· Phase 3· Gilead Sciences· Source
Active, not recruiting
A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation
NCT05090371· Phase 4· Novartis Pharmaceuticals· Source
Recruiting
Maternal Stress on Human Milk and Infant Outcomes
NCT04821544· University of Idaho· Source
Contact: Brook Lang, MD
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error